TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. ORGANOIDS MARKET, BY ORGAN TYPE
6.1. Overview
6.2. Intestine
6.3. Liver
6.4. Stomach
6.5. Pancreas
6.6. Lung
6.7. Brain
6.8. Kidney
6.9. Others
7. ORGANOIDS MARKET, BY APPLICATION
7.1. Overview
7.2. Development of Biology Disease
7.3. Pathology of infectious Disease
7.4. Regenerative Medicines
7.5. Drug Discovery
7.6. Personalized Medicine
7.7. Drug Toxicity
7.8. Efficacy Testing
7.9. Others
8. ORGANOIDS MARKET, BY SOURCE
8.1. Overview
8.2. Pluripotent Stem Cell
8.3. Organ Specific Adult Stem Cell
9. ORGANOIDS MARKET, BY TYPE
9.1. Overview
9.2. Instruments
9.3. Consumables
9.4. Services
10. ORGANOIDS MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Organoids Market,
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Organoids Market,
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. STEMCELL Technologies, Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Cellesce Ltd.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Hubrecht Organoid Technology
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Definigen
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. 3Dnamics, Inc.
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Organoid Therapeutics
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. PeproTech, Inc.
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. THERMO FISHER SCIENTIFIC
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Corning Incorporated (Life Sciences)
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Merck KGgA
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 ORGANOIDS MARKET, SYNOPSIS, 2018-2032
TABLE 2 ORGANOIDS MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
TABLE 3 ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 4 ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 5 ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 6 ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 11 US: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 12 US: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 13 US: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 14 US: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 15 CANADA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 16 CANADA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 17 CANADA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 18 CANADA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 1 EUROPE: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 2 EUROPE: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 3 EUROPE: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 4 EUROPE: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 5 GERMANY: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 6 GERMANY: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 7 GERMANY: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 8 GERMANY: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 9 FRANCE: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 10 FRANCE: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 11 FRANCE: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 12 FRANCE: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 13 ITALY: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 14 ITALY: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 15 ITALY: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 16 ITALY: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 17 SPAIN: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 18 SPAIN: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 19 SPAIN: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 20 SPAIN: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 21 UK: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 22 UK: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 23 UK: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 24 UK: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 25 REST OF EUROPE: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 26 REST OF EUROPE: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 27 REST OF EUROPE: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 28 REST OF EUROPE: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 33 JAPAN: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 34 JAPAN: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 35 JAPAN: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 36 JAPAN: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 37 CHINA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 38 CHINA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 39 CHINA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 40 CHINA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 41 INDIA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 42 INDIA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 43 INDIA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 44 INDIA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 45 AUSTRALIA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 46 AUSTRALIA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 47 AUSTRALIA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 48 AUSTRALIA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 49 SOUTH KOREA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 50 SOUTH KOREA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 51 SOUTH KOREA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 52 SOUTH KOREA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 61 MIDDLE EAST: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 62 MIDDLE EAST: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 63 MIDDLE EAST: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 64 MIDDLE EAST: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 65 AFRICA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 66 AFRICA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 67 AFRICA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 68 AFRICA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
TABLE 69 LATIN AMERICA: ORGANOIDS MARKET, BY ORGAN TYPE, 2018-2032 (USD BILLION)
TABLE 70 LATIN AMERICA: ORGANOIDS MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
TABLE 71 LATIN AMERICA: ORGANOIDS MARKET, BY SOURCE, 2018-2032 (USD BILLION)
TABLE 72 LATIN AMERICA: ORGANOIDS MARKET, BY TYPE, 2018-2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE ORGANOIDS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE ORGANOIDS MARKET
FIGURE 4 ORGANOIDS MARKET, SHARE (%), BY ORGAN TYPE, 2022
FIGURE 5 ORGANOIDS MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 ORGANOIDS MARKET, SHARE (%), BY SOURCE, 2022
FIGURE 7 ORGANOIDS MARKET, SHARE (%), BY TYPE, 2022
FIGURE 8 ORGANOIDS MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ORGANOIDS MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ORGANOIDS MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ORGANOIDS MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ORGANOIDS MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 ORGANOIDS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 14 STEMCELL TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 STEMCELL TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 16 CELLESCE LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 CELLESCE LTD.: SWOT ANALYSIS
FIGURE 18 HUBRECHT ORGANOID TECHNOLOGY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 HUBRECHT ORGANOID TECHNOLOGY: SWOT ANALYSIS
FIGURE 20 DEFINIGEN: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 DEFINIGEN: SWOT ANALYSIS
FIGURE 22 3DNAMICS, INC..: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 3DNAMICS, INC..: SWOT ANALYSIS
FIGURE 24 ORGANOID THERAPEUTICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ORGANOID THERAPEUTICS: SWOT ANALYSIS
FIGURE 26 PEPROTECH, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 PEPROTECH, INC.: SWOT ANALYSIS
FIGURE 28 THERMO FISHER SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 THERMO FISHER SCIENTIFIC: SWOT ANALYSIS
FIGURE 30 CORNING INCORPORATED (LIFE SCIENCES): FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 CORNING INCORPORATED (LIFE SCIENCES): SWOT ANALYSIS
FIGURE 32 MERCK KGGA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 MERCK KGGA: SWOT ANALYSIS
